Operating Lease, Right-of-Use Asset of HAEMONETICS CORP from 29 Jun 2019 to 29 Mar 2025

Taxonomy & unit: us-gaap: USD
Description: Amount of lessee's right to use underlying asset under operating lease.
Summary: HAEMONETICS CORP quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 29 Jun 2019 to 29 Mar 2025.
HAEMONETICS CORP Operating Lease, Right-of-Use Asset for the quarter ending 29 Mar 2025 was $47,492,000, a 14% decline year-over-year.
Source SEC data: View on sec.gov

Operating Lease, Right-of-Use Asset, Quarterly (USD)

Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

HAEMONETICS CORP Quarterly Operating Lease, Right-of-Use Asset (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q1 2025	$47,492,000	-$7,776,000	-14%	29 Mar 2025	10-K	21 May 2025	2025	FY
Q1 2024	$55,268,000	+$1,855,000	+3.5%	30 Mar 2024	10-K	21 May 2025	2025	FY
Q1 2023	$53,413,000	+$664,000	+1.3%	01 Apr 2023	10-K	20 May 2024	2024	FY
Q1 2022	$52,749,000	-$7,107,000	-12%	02 Apr 2022	10-K	22 May 2023	2023	FY
Q1 2021	$59,856,000	+$7,620,000	+15%	03 Apr 2021	10-K	25 May 2022	2022	FY
Q1 2020	$52,236,000			28 Mar 2020	10-K	26 May 2021	2021	FY
Q4 2019	$54,158,000			28 Dec 2019	10-Q	04 Feb 2020	2020	Q3
Q3 2019	$19,356,000			28 Sep 2019	10-Q	01 Nov 2019	2020	Q2
Q2 2019	$21,217,000			29 Jun 2019	10-Q	06 Aug 2019	2020	Q1

* An asterisk sign (*) next to the value indicates that the value is likely invalid.